Status:

COMPLETED

REnal Sympathetic dEnervaTion as an a Adjunct to Catheter-based VT Ablation

Lead Sponsor:

Vivek Reddy

Conditions:

Ventricular Tachycardia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Despite significant advances in the management of ventricular arrhythmias through the use of ICD therapy, AADs, and catheter-based ablation strategies, considerable challenges remain. The optimal meth...

Detailed Description

The goal of this trial is to test the impact of catheter-based renal sympathetic denervation (RSDN) as an adjunctive treatment for patients with either ischemic or non-ischemic cardiomyopathy undergoi...

Eligibility Criteria

Inclusion

  • ≥ 18 years of age
  • Structural heart disease (post-MI, dilated cardiomyopathy, sarcoid myopathy, hypertrophic cardiomyopathy, chagas-related cardiomyopathy, etc.)
  • Planned for catheter-based ablation of VT
  • All patients will have an existing ICD
  • Accessibility of renal vasculature (determined by renal angiography)
  • Ability to understand the requirements of the study
  • Willingness to adhere to study restrictions and comply with all post- procedural follow-up requirements

Exclusion

  • MI or CVA within 30 days
  • Coronary Artery Bypass Graft (CABG) within 30 days of this procedure
  • Known renovascular abnormalities that would preclude RSDN (eg, renal artery stenosis)
  • GFR \<30 ml/min (unless receiving dialysis)
  • Life expectancy \<1 year for any medical condition
  • Any condition resulting in a contraindication to anticoagulation (e.g. GI bleeding)
  • Inability to give informed consent
  • Known pregnancy or positive -HCG within 7 days of procedure.

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2017

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT01858194

Start Date

March 1 2013

End Date

September 1 2017

Last Update

April 17 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

2

Homolka Hospital

Prague, Czechia, 15030